Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

Gene Therapy

Volumn 7, Issue 3, 2000, Pages 249-254

  Jonuleit, H ^a   Tuting T ^a   Steitz, J ^a   Bruck J ^a   Giesecke, A ^a   Steinbrink, K ^a   Knop, J ^a   Enk, A H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Dendritic cells; Genetic immunization; Recombinant adenovirus

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNIZATION; CELL CONTACT; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS RECOMBINANT;

EID: 0342948925     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301077     Document Type: Article

References (20)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
2. Romani N et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Meth 1996; 196: 137-151.
3. Jonuleit H et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27: 3135-3142.
4. Schuler G, Steinman RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 1997; 186: 1183-1187.
5. van Elsas A et al. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur J Immunol 1996; 26: 1683-1689.
6. Nestle FO et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 1998; 4: 328-332.
7. Tüting T, DeLeo AB, Lotze MT, Storkus WJ. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or 'self' antigens induce antitumor immunity in vivo. Eur J Immunol 1997; 27: 2702-2707.
8. Specht JM et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 1997; 186: 1213-1221.
9. Song W et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997; 186: 1247-1256.
10. Wan Y et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum Gene Ther 1997; 8: 1355-1363.
11. Gong J et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Therapy 1997; 4: 1023-1028.
12. Perez-Diez A et al. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene. Cancer Res 1998; 58: 5305-5309.
13. De Veerman M et al. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. J Immunol 1999; 162: 144-151.
14. Arthur JF et al. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 1997; 4: 17-25.
15. Labeur MS et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999; 162: 168-175.
16. Mackey MF et al. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 1998; 161: 2094-2098.
17. Brossart P et al. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood 1998; 92: 4238-4247.
18. Tillman BW et al. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol 1999; 162: 6378-6383.
19. Diao J et al. Human PBMC-derived dendritic cells transduced with adenovirus vector induce cytotoxic T-lymphocyte responses against vector-encoded antigen in vitro. Gene Therapy 1999; 6: 845-849.
20. Hardy S et al. Construction of adenovirus vectors through Crelox recombination. J Virol 1997; 71: 1842-1849.